Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Chronic Heart Failure

  Free Subscription


Articles published in J Cardiol

Retrieve available abstracts of 93 articles:
HTML format



Single Articles


    April 2023
  1. JOKI Y, Konishi H, Takasu K, Minamino T, et al
    Tofogliflozin, a sodium-glucose cotransporter 2 inhibitor, improves pulmonary vascular remodeling due to left heart disease in mice.
    J Cardiol. 2023;81:347-355.
    PubMed     Abstract available


  2. SHINKAWA T, Ichihara Y, Saito S, Ishido M, et al
    Ventricular assist device for end-stage adult congenital heart disease patients: Current status.
    J Cardiol. 2023;81:378-384.
    PubMed     Abstract available


    March 2023
  3. KINOSHITA M, Saito M, Inoue K, Nakagawa H, et al
    Role of the right ventricular contractile reserve during low-load exercise in predicting heart failure readmission.
    J Cardiol. 2023 Mar 8:S0914-5087(23)00049-7. doi: 10.1016/j.jjcc.2023.
    PubMed     Abstract available


  4. IMAMURA T, Narang N, Kinugawa K
    Clinical implications of remote dielectric sensing system to estimate lung fluid levels.
    J Cardiol. 2023;81:276-282.
    PubMed     Abstract available


    February 2023
  5. MISUMI K, Matsue Y, Nogi K, Fujimoto Y, et al
    Derivation and validation of a machine learning-based risk prediction model in patients with acute heart failure.
    J Cardiol. 2023 Feb 27:S0914-5087(23)00045-X. doi: 10.1016/j.jjcc.2023.
    PubMed     Abstract available


  6. TSUTSUI H, Sakamaki H, Momomura SI, Sakata Y, et al
    Cost-effectiveness analysis of Empagliflozin in patients with heart failure with reduced ejection fraction in Japan based on the EMPEROR-reduced trial.
    J Cardiol. 2023 Feb 27:S0914-5087(23)00046-1. doi: 10.1016/j.jjcc.2023.
    PubMed     Abstract available


  7. WATANABE K, Arimoto T, Watanabe T, Otaki Y, et al
    Prognostic impact of plasma xanthine oxidoreductase activity in patients with heart failure with atrial fibrillation.
    J Cardiol. 2023 Feb 21:S0914-5087(23)00042-4. doi: 10.1016/j.jjcc.2023.
    PubMed     Abstract available


  8. LI M, Ma W, Fan F, Yi T, et al
    Renal denervation in management of heart failure with reduced ejection fraction: A systematic review and meta-analysis.
    J Cardiol. 2023 Feb 7:S0914-5087(23)00021-7. doi: 10.1016/j.jjcc.2023.
    PubMed     Abstract available


    December 2022
  9. KINUGAWA K, Matsukawa M, Nakamura Y, Aihara M, et al
    Impact of tolvaptan add-on treatment on patients with heart failure requiring long-term congestion management: A retrospective cohort study using a medical claim database in Japan.
    J Cardiol. 2022 Dec 29:S0914-5087(22)00323-9. doi: 10.1016/j.jjcc.2022.
    PubMed     Abstract available


  10. SHIMOMOTO R, Kubo T, Yamanaka F, Tsuchihashi-Makaya M, et al
    Current state of knowledge and information sharing among home healthcare professionals involved in heart failure management.
    J Cardiol. 2022 Dec 13:S0914-5087(22)00312-4. doi: 10.1016/j.jjcc.2022.
    PubMed     Abstract available


  11. CHIBA Y, Iwano H, Aoyagi H, Tamaki Y, et al
    Associations of right ventricular pulsatile load and cardiac power output to clinical outcomes in heart failure: Difference from systemic circulation.
    J Cardiol. 2022 Dec 8:S0914-5087(22)00311-2. doi: 10.1016/j.jjcc.2022.
    PubMed     Abstract available


  12. OHTE N, Tanaka A, Kitada S, Yamada T, et al
    Influence of left ventricular ejection fraction on the reduction in N-terminal pro-brain natriuretic peptide by canagliflozin in patients with heart failure and type 2 diabetes: a sub analysis of the CANDLE trial.
    J Cardiol. 2022 Dec 5:S0914-5087(22)00295-7. doi: 10.1016/j.jjcc.2022.
    PubMed     Abstract available


  13. NAMBA T, Masaki N, Hitomi Y, Ishinoda Y, et al
    Association of serum nitric oxide metabolite level with mortality in patients undergoing coronary angiography.
    J Cardiol. 2022;80:578-584.
    PubMed     Abstract available


  14. TSUDA E, Ito Y, Kato Y, Sakaguchi H, et al
    Thirty-year outcome in children with hypertrophic cardiomyopathy based on the type.
    J Cardiol. 2022;80:557-562.
    PubMed     Abstract available


    November 2022
  15. KIDA K, Miyajima I, Suzuki N, Greenberg BH, et al
    Nutritional Management of Heart Failure.
    J Cardiol. 2022 Nov 9. pii: S0914-5087(22)00272.
    PubMed     Abstract available


  16. ZHANG T, Gao Z, Chen K
    Exosomal microRNAs: potential targets for the prevention and treatment of diabetic cardiomyopathy.
    J Cardiol. 2022;80:423-431.
    PubMed     Abstract available


    October 2022
  17. LEIVA O, Jenkins A, Rosovsky RP, Leaf RK, et al
    Predictors of increased risk of adverse cardiovascular outcomes among patients with myeloproliferative neoplasms and atrial fibrillation.
    J Cardiol. 2022 Oct 29. pii: S0914-5087(22)00269.
    PubMed     Abstract available


  18. IMAMURA T
    Clinical implication of difficulty initiating sleep in patients with heart failure.
    J Cardiol. 2022 Oct 15. pii: S0914-5087(22)00257.
    PubMed    


  19. HASHIMOTO S, Kitakata H, Kohsaka S, Fujisawa D, et al
    Confidence in self-care after heart failure hospitalization.
    J Cardiol. 2022 Oct 11. pii: S0914-5087(22)00254.
    PubMed     Abstract available


    September 2022
  20. NODA T, Kamiya K, Hamazaki N, Nozaki K, et al
    Prognostic impact of the coexistence of hepato-renal dysfunction and frailty in patients with heart failure.
    J Cardiol. 2022 Sep 24. pii: S0914-5087(22)00223.
    PubMed     Abstract available


  21. ISHIZAKA S, Iwano H, Tsujinaga S, Murayama M, et al
    Determinants of exercise capacity in patients with heart failure without left ventricular hypertrophy.
    J Cardiol. 2022 Sep 16. pii: S0914-5087(22)00227.
    PubMed     Abstract available


  22. MAEKAWA Y, Takamisawa I, Takano H, Takayama M, et al
    Percutaneous transluminal septal myocardial ablation: past, present, and future.
    J Cardiol. 2022;80:211-217.
    PubMed     Abstract available


    August 2022
  23. KOIZUMI T, Kamada R, Watanabe M, Yokoshiki H, et al
    Predictors of cardiovascular mortality after an electrical storm in patients with structural heart disease.
    J Cardiol. 2022;80:167-171.
    PubMed     Abstract available


  24. HATANO M, Jimba T, Fujiwara T, Tsuji M, et al
    Late-onset right ventricular failure after continuous-flow left ventricular assist device implantation: case presentation and review of the literature.
    J Cardiol. 2022;80:110-115.
    PubMed     Abstract available


  25. ISHIDO M
    Current status and challenges of Pediatric heart transplantation in Japan.
    J Cardiol. 2022;80:145-148.
    PubMed     Abstract available


    June 2022
  26. KARIM A, Muhammad T, Shah I, Khan J, et al
    A multistrain probiotic reduces sarcopenia by modulating Wnt signaling biomarkers in patients with chronic heart failure.
    J Cardiol. 2022 Jun 21. pii: S0914-5087(22)00152.
    PubMed     Abstract available


  27. AMISAKI R, Kato M, Fujiyama M, Matsuda E, et al
    Difficulty initiating sleep in patients with heart failure: Impact of left atrial pressure.
    J Cardiol. 2022 Jun 17. pii: S0914-5087(22)00136.
    PubMed     Abstract available


  28. YOKOYAMA Y, Kataoka N, Nakai M, Matsuo A, et al
    A new biomarker of cardiac resynchronization therapy response: cGMP to mature BNP ratio.
    J Cardiol. 2022;79:727-733.
    PubMed     Abstract available


  29. NODA T, Lu X, Ishiguro Y, Ikuemonisan J, et al
    Cost-effective analysis of automated programming optimization in cardiac resynchronization therapy: Holistic Markov modelling.
    J Cardiol. 2022;79:734-739.
    PubMed     Abstract available


  30. KIUCHI S, Ikeda T
    Management of hypertension associated with cardiovascular failure.
    J Cardiol. 2022;79:698-702.
    PubMed     Abstract available


    April 2022
  31. AMIOKA N, Takaishi A, Nakamura K, Endo T, et al
    Innovative clinical pathway shortened the length of hospital stay and prevented readmission in patients with acute decompensated heart failure.
    J Cardiol. 2022 Apr 12. pii: S0914-5087(22)00074.
    PubMed     Abstract available


    March 2022
  32. IWANO H, Utsunomiya H, Shibayama K, Tanaka H, et al
    Results of PRospect trial to Elucidate the utility of EchocarDiography-based Cardiac ouTput in acute heart failure (PREDICT).
    J Cardiol. 2022 Mar 17. pii: S0914-5087(22)00055.
    PubMed     Abstract available


  33. NAKAI T, Ikeya Y, Kogawa R, Okumura Y, et al
    Cardiac resynchronization therapy: Current status and near-future prospects.
    J Cardiol. 2022;79:352-357.
    PubMed     Abstract available


  34. OKI T, Ishii S, Takigami Y, Eda Y, et al
    Re-worsening left ventricular ejection fraction after response to cardiac resynchronization therapy.
    J Cardiol. 2022;79:358-364.
    PubMed     Abstract available


    February 2022
  35. YOSHIKAWA T
    New paradigm shift in the pharmacotherapy for heart failure-where are we now and where are we heading?
    J Cardiol. 2022 Feb 25. pii: S0914-5087(22)00031.
    PubMed     Abstract available


  36. SATO Y, Yoshihisa A, Takeishi R, Ohara H, et al
    B-type natriuretic peptide is associated with the occurrence of bleeding events in heart failure patients with a history of coronary artery disease.
    J Cardiol. 2022 Feb 22. pii: S0914-5087(22)00026.
    PubMed     Abstract available


  37. KIDA K, Nabeta T, Ishida M, Shiono T, et al
    D-dimer levels in patients with nonvalvular atrial fibrillation and acute heart failure treated with edoxaban.
    J Cardiol. 2022 Feb 8. pii: S0914-5087(22)00015.
    PubMed     Abstract available


    January 2022
  38. MIYANAGA S, Komukai K, Kubota T, Shirasaki K, et al
    Cancer and malnutrition were independently associated with a poor prognosis in patients with heart failure.
    J Cardiol. 2022;79:15-20.
    PubMed     Abstract available


  39. WANG S, Jiang C, Zhao L, Sun S, et al
    Metabolic maturation during postnatal right ventricular development switches to heart-contraction regulation due to volume overload.
    J Cardiol. 2022;79:110-120.
    PubMed     Abstract available


  40. BRONS M, Rutten FH, Zuithoff NPA, Oerlemans MIFJ, et al
    Disease management with home telemonitoring aimed at substitution of usual care in the Netherlands: Post-hoc analyses of the e-Vita HF study.
    J Cardiol. 2022;79:1-5.
    PubMed     Abstract available


    December 2021
  41. YAKU H, Kaneda K, Kitamura J, Kato T, et al
    Kampo medicine for the holistic approach to older adults with heart failure.
    J Cardiol. 2021 Dec 30. pii: S0914-5087(21)00366.
    PubMed     Abstract available


  42. KAKUTANI N, Yokota T, Fukushima A, Obata Y, et al
    Impact of citrus fruit intake on the mental health of patients with chronic heart failure.
    J Cardiol. 2021 Dec 23. pii: S0914-5087(21)00359.
    PubMed     Abstract available


  43. SHINOMIYA H, Koyama S, Tanada Y, Takahashi N, et al
    Corrigendum to "Left ventricular end-diastolic pressure and ejection fraction correlate independently with high-sensitivity cardiac troponin-T concentrations in stable heart failure" 65 (2015) 526-530 6.
    J Cardiol. 2021 Dec 22. pii: S0914-5087(21)00317.
    PubMed    


  44. FUKATA M, Yamasaki H, Sai E, Ogawa K, et al
    Impact of adaptive cardiac resynchronization therapy in patients with systolic heart failure: Beyond QRS duration and morphology.
    J Cardiol. 2021 Dec 19. pii: S0914-5087(21)00315.
    PubMed     Abstract available


  45. SAITO C, Jujo K, Kametani M, Arai K, et al
    Prognostic impact of right ventricular function affected by pulmonary hypertension in hospitalized heart failure patients.
    J Cardiol. 2021 Dec 18. pii: S0914-5087(21)00279.
    PubMed     Abstract available


  46. SAKU K, Yokota S, Nishikawa T, Kinugawa K, et al
    Interventional heart failure therapy: A new concept fighting against heart failure.
    J Cardiol. 2021 Dec 16. pii: S0914-5087(21)00339.
    PubMed     Abstract available


  47. ODAJIMA S, Tanaka H, Fujimoto W, Kuroda K, et al
    Efficacy of Renin-angiotensin-aldosterone-system inhibitors for heart failure with preserved ejection fraction and left ventricular hypertrophy -from the KUNIUMI Registry Acute Cohort.
    J Cardiol. 2021 Dec 16. pii: S0914-5087(21)00357.
    PubMed     Abstract available


  48. MINATOGUCHI S
    Heart failure and its treatment from the perspective of sympathetic nerve activity.
    J Cardiol. 2021 Dec 16. pii: S0914-5087(21)00337.
    PubMed     Abstract available


  49. YAMAMOTO M, Ishizu T, Seo Y, Nakagawa D, et al
    Pathophysiological role of right ventricular function and interventricular functional mismatch in the development of pulmonary edema in acute heart failure.
    J Cardiol. 2021 Dec 16. pii: S0914-5087(21)00342.
    PubMed     Abstract available


  50. NISHIDA H, Ota T, Onsager D, Grinstein J, et al
    Ten-year, single center experience of ambulatory axillary intra-aortic balloon pump support for heart failure.
    J Cardiol. 2021 Dec 8. pii: S0914-5087(21)00320.
    PubMed     Abstract available


  51. OISHI H, Okumura T, Ohashi K, Kimura Y, et al
    Prognostic impact of transcardiac gradient of follistatin-like 1 reflecting hemodynamics in patients with dilated cardiomyopathy.
    J Cardiol. 2021;78:524-532.
    PubMed     Abstract available


    November 2021
  52. HARADA T, Kagami K, Kato T, Obokata M, et al
    Echocardiography in the diagnostic evaluation and phenotyping of heart failure with preserved ejection fraction.
    J Cardiol. 2021 Nov 29. pii: S0914-5087(21)00313.
    PubMed     Abstract available


  53. YAMASHITA M, Kamiya K, Hamazaki N, Nozaki K, et al
    Work status before admission relates to prognosis in older patients with heart failure partly through social frailty.
    J Cardiol. 2021 Nov 21. pii: S0914-5087(21)00307.
    PubMed     Abstract available


  54. NAKAO Y, Kawakami H, Saito M, Inoue K, et al
    Cost-Effectiveness of long-term tolvaptan administration for chronic heart failure treatment in Japan.
    J Cardiol. 2021 Nov 16. pii: S0914-5087(21)00287.
    PubMed     Abstract available


  55. TSAI YL, Chou RH, Lu YW, Chang CC, et al
    Associations between galectin-1, left ventricular diastolic dysfunction, and heart failure with preserved ejection fraction.
    J Cardiol. 2021 Nov 10. pii: S0914-5087(21)00258.
    PubMed     Abstract available


    October 2021
  56. OKADA M, Inoue K
    Catheter ablation of atrial fibrillation with left ventricular systolic dysfunction: Potential approach to the cause of heart failure-authors' reply.
    J Cardiol. 2021;78:347-348.
    PubMed    


    September 2021
  57. IWAHASHI N, Kirigaya J, Abe T, Horii M, et al
    Clinical usefulness of left ventricular outflow tract velocity time integral for heart failure with reduced ejection fraction with rapid atrial fibrillation during landiolol treatment.
    J Cardiol. 2021 Sep 23. pii: S0914-5087(21)00242.
    PubMed     Abstract available


    August 2021
  58. KONISHI M, Akiyama E, Shibata A, Kida K, et al
    Moderate potassium lowering effect of exogenous atrial natriuretic peptide in patients with acute heart failure.
    J Cardiol. 2021 Aug 20. pii: S0914-5087(21)00197.
    PubMed     Abstract available


  59. KANAI M, Yagishita D, Shoda M, Ejima K, et al
    Clinical outcomes of upgrade to versus de novo cardiac resynchronization therapy in mild heart failure patients with atrioventricular block.
    J Cardiol. 2021 Aug 20. pii: S0914-5087(21)00195.
    PubMed     Abstract available


    June 2021
  60. YAMADA T, Haruki S, Minami Y, Numata M, et al
    The C-reactive protein to prealbumin ratio on admission and its relationship with outcome in patients hospitalized for acute heart failure.
    J Cardiol. 2021 Jun 10. pii: S0914-5087(21)00131.
    PubMed     Abstract available


  61. YANAGIHARA K, Kinugasa Y, Kunimi T, Kaneko S, et al
    Child ego state and self-care behavior change in heart failure patients.
    J Cardiol. 2021 Jun 2. pii: S0914-5087(21)00128.
    PubMed     Abstract available


  62. NISHIKIMI T, Nakagawa Y
    Potential pitfalls when interpreting plasma BNP levels in heart failure practice.
    J Cardiol. 2021 Jun 1. pii: S0914-5087(21)00114.
    PubMed     Abstract available


  63. TOMII D, Horiuchi Y, Gonda Y, Yoshiura D, et al
    The role of the renal resistance index in patients with heart failure with reduced or preserved ejection fraction.
    J Cardiol. 2021 Jun 1. pii: S0914-5087(21)00130.
    PubMed     Abstract available


    May 2021
  64. TSAI YN, Cheng WH, Chang YT, Hsiao YW, et al
    Mechanism of angiotensin receptor-neprilysin inhibitor in suppression of ventricular arrhythmia.
    J Cardiol. 2021 May 28. pii: S0914-5087(21)00108.
    PubMed     Abstract available


  65. HITOMI Y, Nagatomo Y, Yukino M, Yumita Y, et al
    Characterization of tolvaptan response and its impact on the outcome for patients with heart failure.
    J Cardiol. 2021 May 23. pii: S0914-5087(21)00111.
    PubMed     Abstract available


    April 2021
  66. MARUYAMA M, Yasuoka R, Nagano T, Nakazawa G, et al
    Impact of atrial fibrillation/flutter on outcomes of patients with implantable cardioverter defibrillators: A sub-analysis of the Nippon Storm study.
    J Cardiol. 2021 Apr 30. pii: S0914-5087(21)00091.
    PubMed     Abstract available


  67. NAKAMURA T, Tsujita K
    Current trends and future perspectives for heart failure treatment leveraging cGMP modifiers and the practical effector PKG.
    J Cardiol. 2021 Apr 1. pii: S0914-5087(21)00059.
    PubMed     Abstract available


  68. NAKAJIMA DOI S, Seguchi O, Yamamoto M, Fujita T, et al
    Impact of bridge-to-bridge strategies from paracorporeal to implantable left ventricular assist devices on the pre-heart transplant outcome: A single-center analysis of 134 cases.
    J Cardiol. 2021;77:408-416.
    PubMed     Abstract available


    March 2021
  69. YOKOYAMA H, Shishido K, Tobita K, Moriyama N, et al
    Impact of age on mid-term clinical outcomes and left ventricular reverse remodeling after cardiac resynchronization therapy.
    J Cardiol. 2021;77:254-262.
    PubMed     Abstract available


  70. DAYANAND S, Martinez JM, Figueredo VM, Gupta S, et al
    Mechanical Circulatory Support in Women.
    J Cardiol. 2021;77:209-216.
    PubMed     Abstract available


    February 2021
  71. MAEMURA K, Ikeda Y, Oki T, Yazaki M, et al
    Clinical significance of ischemia-like electrocardiographic finding during heart failure treatment on left ventricular recovery in patients with non-ischemic dilated cardiomyopathy.
    J Cardiol. 2021 Feb 19. pii: S0914-5087(21)00037.
    PubMed     Abstract available


  72. KIKUCHI A, Taniguchi T, Nakamoto K, Sera F, et al
    Feasibility of home-based cardiac rehabilitation using an integrated telerehabilitation platform in elderly patients with heart failure: A pilot study.
    J Cardiol. 2021 Feb 10. pii: S0914-5087(21)00023.
    PubMed     Abstract available


  73. SOEDA T, Okura H, Saito Y, Nakao K, et al
    Clinical characteristics and in-hospital outcomes in patients aged 80 years or over with cardiac troponin-positive acute myocardial infarction -J-MINUET study.
    J Cardiol. 2021;77:139-146.
    PubMed     Abstract available


  74. NAITO Y, Masuyama T, Ishihara M
    Iron and cardiovascular diseases.
    J Cardiol. 2021;77:160-165.
    PubMed     Abstract available


    January 2021
  75. FUJIMOTO W, Konishi A, Iwasaki M, Toh R, et al
    Precipitating factors and clinical impact of early rehospitalization for heart failure in patients with heart failure in Awaji Island, Japan.
    J Cardiol. 2021 Jan 5. pii: S0914-5087(20)30418.
    PubMed     Abstract available


  76. SHIINA Y, Nagao M, Shimomiya Y, Inai K, et al
    Secondary sarcopenia assessed by computed tomography can predict hospitalization for heart failure in adults with Fontan circulation.
    J Cardiol. 2021;77:10-16.
    PubMed     Abstract available


  77. KANAMORI H, Naruse G, Yoshida A, Minatoguchi S, et al
    Morphological characteristics in diabetic cardiomyopathy associated with autophagy.
    J Cardiol. 2021;77:30-40.
    PubMed     Abstract available


    December 2020
  78. TANAKA H, Yamauchi Y, Imanishi J, Hatani Y, et al
    Effect of ivabradine on left ventricular diastolic function of patients with heart failure with preserved ejection fraction -IVA-PEF study.
    J Cardiol. 2020 Dec 31. pii: S0914-5087(20)30417.
    PubMed     Abstract available


  79. NATANZON SS, Mazin I
    Author's reply: The outcome of acute decompensated heart failure stratified by the Norton scale on admission.
    J Cardiol. 2020 Dec 4. pii: S0914-5087(20)30385.
    PubMed    


  80. IZUMIDA T, Imamura T
    The outcome of acute decompensated heart failure stratified by the Norton scale on admission.
    J Cardiol. 2020 Dec 3. pii: S0914-5087(20)30386.
    PubMed    


  81. IZUMIDA T, Imamura T
    Sarcopenia in patients with cardiovascular disease.
    J Cardiol. 2020;76:636.
    PubMed    


    November 2020
  82. KURODA S, Mizukami A, Hiroki J, Shimizu Y, et al
    Clinical impact of serial change in brain natriuretic peptide before and after catheter ablation in patients with atrial fibrillation and heart failure.
    J Cardiol. 2020 Nov 25. pii: S0914-5087(20)30374.
    PubMed     Abstract available


  83. CHANG WT, Lin CH, Hong CS, Liao CT, et al
    The predictive value of global longitudinal strain in patients with heart failure mid-range ejection fraction.
    J Cardiol. 2020 Nov 21. pii: S0914-5087(20)30359.
    PubMed     Abstract available


  84. HATA R, Kato T, Yaku H, Morimoto T, et al
    Implantable Cardioverter Defibrillator Therapy in Patients with Acute Decompensated Heart Failure with Reduced Ejection Fraction: An Observation from the KCHF Registry.
    J Cardiol. 2020 Nov 12. pii: S0914-5087(20)30339.
    PubMed     Abstract available


    October 2020
  85. MIRO O, Lopez-Diez MP, Rossello X, Gil V, et al
    Analysis of standards of quality for outcomes in acute heart failure patients directly discharged home from emergency departments and their relationship with the emergency department direct discharge rate.
    J Cardiol. 2020 Oct 11. pii: S0914-5087(20)30307.
    PubMed     Abstract available


    September 2020
  86. KOBAYASHI S, Yoshiga Y, Yano M
    Author's reply: The RyR2 - Targeting therapy against lethal arrhythmia.
    J Cardiol. 2020;76:323-324.
    PubMed    


    May 2020
  87. SATO K, Takahashi J, Hao K, Miyata S, et al
    Temporal trends in the prevalence and outcomes of geriatric patients with acute myocardial infarction in Japan-A report from the Miyagi AMI Registry Study.
    J Cardiol. 2020;75:465-472.
    PubMed     Abstract available


    April 2020
  88. KODZISZEWSKA K, Sochanowicz B, Smigielski W, Kruszewski M, et al
    Grey areas and open questions in neprilysin inhibition.
    J Cardiol. 2020;75:462-463.
    PubMed    


  89. CHANG HY, Yin WH
    Response to "Grey Areas and Open Questions in Neprilysin Inhibition".
    J Cardiol. 2020;75:463-464.
    PubMed    


  90. LIANG Y, Wang J, Yu Z, Zhang M, et al
    Comparison between cardiac resynchronization therapy with and without defibrillator on long-term mortality: A propensity score matched analysis.
    J Cardiol. 2020;75:432-438.
    PubMed     Abstract available


    March 2020
  91. CHANG HY, Chen KC, Fong MC, Feng AN, et al
    Recovery of left ventricular dysfunction after sacubitril/valsartan: predictors and management.
    J Cardiol. 2020;75:233-241.
    PubMed     Abstract available


    September 2019
  92. HAYASHI H, Abe Y, Morita Y, Yamaji Y, et al
    Prognostic significance of moderate primary mitral regurgitation and concomitant paroxysmal atrial fibrillation.
    J Cardiol. 2019 Sep 12. pii: S0914-5087(19)30276.
    PubMed     Abstract available


  93. YAMASAKI H, Sekiguchi Y, Gosho M, Nogami A, et al
    Design and results of aCRT MID-Q study: Adoption of adaptive CRT in patients with normal AV conduction and moderately wide left bundle branch block.
    J Cardiol. 2019 Sep 3. pii: S0914-5087(19)30262.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Chronic Heart Failure is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: